$PCVX news
The latest PCVX stock news: headlines, filings, AI summaries and sentiment for $PCVX, updated around the clock.
- Vaxcyte Reports Q3 GAAP EPS of -$1.99, Exceeding Analyst Expectations
- Vaxcyte, Inc. - 10-Q Filing
- Vaxcyte, Inc. - 8-K Filing
- Vaxcyte, Inc. - 8-K Filing
- Vaxcyte Announces $1 Billion Financing Through Equity and Convertible Notes
- Tech Momentum Lifts Nasdaq as Treasury Yields Rise
- Vaxcyte Announces Separate $500M Offerings for Equity/Pre-Funded Warrants and Convertible Notes
- Stocks Making Significant Moves Midday: Microsoft, SpaceX, Vaxcyte, Banco Bradesco, DraftKings Among Others
- Vaxcyte Shares Rise on Positive Phase 3 Data for Pneumonia Vaccine Candidate
- Vaxcyte, Inc. - 8-K Filing
- Vaxcyte Hires Pharma Veterans Ahead of Key Vaccine Trial Results
- Vaxcyte CFO Sells Shares for Tax Obligations Amid Strong Share Performance
- Vaxcyte Executive Sells Shares After Exercising Options Struck at $5.35
- Vaxcyte CEO Disposes Shares for Tax Withholding; Investors Should Focus on Upcoming Clinical Data
- Vaxcyte CFO Sells Shares for Tax Obligations Amid Strong Share Performance and High Cash Reserves
- Vaxcyte, Inc. - 8-K Filing
- Vaxcyte, Inc. - 8-K Filing
- Vaxcyte, Inc. - 8-K Filing
- Vaxcyte Doses First Patient in Phase 1 Trial for Group A Strep Vaccine
- Vaxcyte Initiates Phase 1 Study for VAX-A1 Vaccine Candidate
- Vaxcyte Completes Enrollment in Phase 3 VAX-31 Clinical Trials